4.5 Article

LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

LOX/LOXL in pulmonary fibrosis: potential therapeutic targets

Lijun Chen et al.

JOURNAL OF DRUG TARGETING (2019)

Article Medicine, Research & Experimental

lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis

Li Qi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Oncology

Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling

Yubo Tang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Biochemistry & Molecular Biology

Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1

Bo Long et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR

Wei Wei et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2017)

Article Biochemistry & Molecular Biology

IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling

Yuanyuan Lu et al.

NATURE MEDICINE (2017)

Article Multidisciplinary Sciences

An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation

Yingyi Zhang et al.

PLOS ONE (2017)

Article Neurosciences

MicroRNA-Let-7a regulates the function of microglia in inflammation

Kyoung Joo Cho et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2015)

Review Oncology

Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond

Christopher Delaney et al.

CHINESE JOURNAL OF CANCER (2015)

Article Biochemistry & Molecular Biology

Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway

Firdous Ahmad Bhat et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)

Article Urology & Nephrology

Prostate cancer epidemiology in the United States

Otis W. Brawley

WORLD JOURNAL OF UROLOGY (2012)

Article Multidisciplinary Sciences

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

Anindita Das et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Pharmacology & Pharmacy

Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells

Fei Shen et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Review Oncology

ERBB receptors and cancer: The complexity of targeted inhibitors

NE Hynes et al.

NATURE REVIEWS CANCER (2005)

Article Multidisciplinary Sciences

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

J Lapointe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell

HM Kagan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2003)

Review Biochemistry & Molecular Biology

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

J Schlessinger

Article Cell Biology

Adriamycin-induced heart failure: mechanisms and modulation

P Singal et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)